Jetjono, it could be any of the above. But IMO it is more likely shares have been issued in return for capital investment, probably for Exergen's CHTD plant.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
